Showing results (141-150 of 344) with videos related to
Sort By:
Pageof 35
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.Journal of Cachexia, Sarcopenia and Muscle|June 19, 2021
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancerHan Gyul Yoon, Dongryul Oh, Jae Myoung Noh, et al.Oncotarget|February 25, 2016
The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinomaBo Mi Ku, Seong Yoon Yi, Jiae Koh, et al.Cancer Research and Treatment|May 30, 2018
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung CancerJiyun Lee, Joon Ho Shim, Woong-Yang Park, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinomaJiyun Lee, Hyun Ae Jung, Youjin Kim, et al.Cancer Chemotherapy and Pharmacology|November 26, 2010
Safety and pharmacokinetics of intrathecal administration of pemetrexed in ratsJong-Mu Sun, Mi Hyun Nam, Jae Yong Chung, et al.Biomaterials|October 30, 2015
Highly dense, optically inactive silica microbeads for the isolation and identification of circulating tumor cellsChang Eun Yoo, Hui-Sung Moon, Yeon Jeong Kim, et al.Japanese Journal of Clinical Oncology|February 22, 2020
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practiceJiyun Lee, Bo Mi Ku, Joon Ho Shim, et al.European Journal of Immunology|January 28, 2021
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancerBo Mi Ku, Youjin Kim, Kyoung Young Lee, et al.Stem Cell Research|January 12, 2013
Prevention of β-amyloid induced toxicity in human iPS cell-derived neurons by inhibition of Cyclin-dependent kinases and associated cell cycle eventsXiaohong Xu, Ying Lei, Jie Luo, et al.Pageof 35